Gilead Sciences Inc. has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance effective ...

Galux has signed a research agreement with Boehringer Ingelheim to jointly explore the application of AI in precision protein ...

Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.

Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...

Harbour BioMed, a global biopharmaceutical company, has announced a multi-year, global strategic collaboration and license ...

MEDI&GENE, a biopharmaceutical company, has entered into a Catalyze agreement with Eli Lilly and Company to advance a ...

Lindus Health and Quotient Sciences have partnered to enable enhanced patient recruitment for Phase I-IIa clinical studies ...

ADEL Inc., a biopharma company, has entered into an exclusive worldwide license agreement with Sanofi for the development and ...

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production, and commercialization of ...

Grifols S.A. has received certification from the European Medicines Agency (EMA) for the entire value chain of Grifols Egypt ...

TreeFrog Therapeutics, a French biotech, has appointed Mark Rothera, as Chief Executive Officer and Board member.